Venus Remedies Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the EQ series, declined by 4.61% on the day, reaching a low of Rs 819.65 before settling at Rs 833.5, exactly at the 5% lower circuit band. This price band capped the maximum daily loss allowed by the exchange, effectively halting further declines. The presence of unfilled supply is evident as sellers remained eager to exit but buyers were absent, causing the price to freeze at the floor. Such a scenario is typical in micro-cap stocks like Venus Remedies Ltd, where liquidity constraints exacerbate exit difficulties. With unfilled sell orders at Rs 833.5 and limited buyer interest, how severe is the exit problem for this micro-cap stock?

Delivery and Volume Analysis

Delivery volumes on 27 Mar rose by 21.97% compared to the 5-day average, reaching 36,010 shares. On a lower circuit day, rising delivery volume signals genuine liquidation by holders rather than speculative short-selling. This suggests that investors are offloading actual holdings, indicating capitulation or forced selling pressure. The total traded volume on 30 Mar was 0.32173 lakh shares, with a turnover of Rs 2.70 crore, reflecting a relatively low liquidity environment. The limited volume despite the circuit lock implies that much of the supply remained unfilled, reinforcing the notion of sellers queuing without buyers. Does the surge in delivery volume on a lower circuit day indicate that selling pressure has reached a climax or is further liquidation likely?

Intraday Price Action

The stock opened at Rs 843.00, already down 2.29% from the previous close, and traded narrowly around this level before descending to the circuit low of Rs 819.65. The absence of a significant intraday recovery or bounce suggests persistent selling pressure throughout the session. The narrow intraday range and the stock’s inability to rebound from the opening gap-down reinforce the impression of sustained demand absence. This steady slide to the circuit floor highlights the market’s reluctance to engage at these prices, leaving sellers trapped. Is this steady decline to the lower circuit a sign of capitulation or a prelude to further weakness?

Moving Averages and Trend Context

Technically, Venus Remedies Ltd trades below its 5-day moving average but remains above the 20-day, 50-day, 100-day, and 200-day moving averages. This mixed positioning suggests short-term weakness but some underlying medium- to long-term support remains intact. However, the breach of the 5-day average confirms recent selling momentum, which culminated in the lower circuit lock. Does the technical profile of Venus Remedies show any nearby support, or is more downside likely?

Liquidity and Exit Risk

With a market capitalisation of approximately Rs 1,153 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is modest, with a trade size of Rs 0.08 crore based on 2% of the 5-day average traded value. This limited liquidity means that meaningful positions face significant exit friction, especially on a lower circuit day when supply overwhelms demand. Sellers who wish to exit may find themselves locked in for multiple sessions until buying interest returns. This liquidity constraint amplifies the risk of prolonged price stagnation at the circuit floor. How deep is the exit problem for Venus Remedies and what would need to change for normal trading to resume?

Industry and Sector Context

Operating within the Pharmaceuticals & Biotechnology sector, Venus Remedies Ltd faces sectoral pressures that have contributed to its recent underperformance. The stock underperformed its sector by 1.35% on the day, while the sector itself declined by 1.19%, and the Sensex fell 1.11%. This relative weakness indicates that the stock’s decline is more stock-specific than market-driven, further underscoring the significance of the lower circuit event.

Conclusion: Severity and Liquidity Caveats

The 5% lower circuit lock for Venus Remedies Ltd reflects a day where supply overwhelmed demand to the extent that the exchange had to intervene to prevent further price erosion. Rising delivery volumes confirm that this is genuine selling by holders rather than speculative short-selling, signalling capitulation or forced liquidation. The stock’s position below the 5-day moving average confirms short-term weakness, while its micro-cap status and limited liquidity raise the risk of prolonged exit difficulties. Sellers face a challenging environment where meaningful exits may be delayed until buying interest returns. After a 5% single-day loss at lower circuit, is Venus Remedies approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →